DNA Jan 2026 4.000 put

OPR - OPR Delayed Price. Currency in USD

Add to watchlist

2.9000

0.0000

(0.00%)

As of 09:51AM EDT. Market open.

Simply Wall St.
Recent uptick might appease Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) institutional owners after losing 25% over the past year
Key Insights Significantly high institutional ownership implies Ginkgo Bioworks Holdings' stock price is sensitive to...
PR Newswire
Ginkgo Bioworks Announces Date of First Quarter 2024 Results Presentation
Ginkgo Bioworks Holdings, Inc. (NYSE: DNA, "Ginkgo"), which is building the leading platform for cell programming and biosecurity, today announced that it plans to host a presentation and Q&A session reviewing business performance for the first quarter ended March 31, 2024, on Thursday, May 9, 2024, beginning at 5:30 p.m. ET.
PR Newswire
Ginkgo Bioworks Announces Nomination of Myrtle Potter and Ross Fubini to Board of Directors
Today, Ginkgo Bioworks (NYSE: DNA), which is building the leading platform for cell programming and biosecurity, announced the nomination of Myrtle Potter and Ross Fubini for election as independent directors at Ginkgo's upcoming annual meeting, scheduled to be held on June 13, 2024.